Application of a MYC degradation screen identifies sensitivity to CDK9 inhibitors in KRAS-mutant pancreatic cancer

Stabilization of the MYC oncoprotein by KRAS signaling is a requirement for growth of pancreatic ductal adenocarcinomas (PDAC). However, current understanding of how MYC protein stability is regulated in MYC-dependent cancers such as KRAS-mutant PDAC is incomplete. We developed a flow cytometry-base...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Sci Signal
Main Authors: Blake, Devon R., Vaseva, Angelina V., Hodge, Richard G., Kline, McKenzie P., Gilbert, Thomas S.K., Tyagi, Vikas, Huang, Daowei, Whiten, Gabrielle C., Larson, Jacob E., Wang, Xiaodong, Pearce, Kenneth H., Herring, Laura E., Graves, Lee M., Frye, Stephen V., Emanuele, Michael J., Cox, Adrienne D., Der, Channing J.
Format: Artigo
Sprog:Inglês
Udgivet: 2019
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6728149/
https://ncbi.nlm.nih.gov/pubmed/31311847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scisignal.aav7259
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker